Shares of Abbott Laboratories rose 4.62% to $123.22 Thursday, on what proved to be an all-around favorable trading session ...

Abbott Laboratories (NYSE: NYSE:ABT) has demonstrated resilience and growth potential in the healthcare sector, maintaining a strong financial profile despite facing various challenges. According to ...

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...

Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to ...

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes ...

Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

Robert F. Kennedy Jr.'s nomination as Secretary of Health and Human Services has sparked debate due to his previously earned ...

This report covers recent health news, including Robert F. Kennedy Jr.'s legal fees from Merck litigations, rejections of a ...

Texas Gov. Greg Abbott on Thursday called on Congress to reimburse Texas for its border security operation, Operation Lone ...

The Republican governor blamed the just-ended presidency of Democrat Joe Biden for the state having to step up to secure its border with Mexico.

In a letter to U.S. congressional leaders, the governor blamed previous border security policy for leaving Texas “defenseless,” forcing state officials to spend billions.